Results 11 to 20 of about 61,970 (240)
Multidrug-resistant tuberculosis [PDF]
BMC Infectious Diseases, 2008 Background With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of ...
McNerney Ruth, Zager Ellen M
doaj +6 more sources
Multidrug-resistant tuberculosis
Revista Ciencias Biomédicas, 2013 Introduction: tuberculosis is an increasing problem of global health and the microbialdrug resistance a generating element of worry.Clinical case: 19 year-old patient, who admitted to the emergency room for presentinghemoptysis and who had history of ...
Álvarez-Gaviria Manuel +5 more
doaj +12 more sources
Multidrug-resistant tuberculosis [PDF]
The Lancet, 2019 The ideal number of drugs needed and treatment duration are crucial issues in the management of multidrug-resistant tuberculosis (MDR-TB). Thus, we read with interest the Article by the Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017,1 the results of which support our proposal,2 from 2015, to classify anti ...
Caminero, José A . +2 more
+13 more sources
The Lancet Global Health, 2022 Summary: Background: Estimates suggest that at least 30 000 children develop multidrug-resistant or rifampicin-resistant tuberculosis each year. Despite household contact management (HCM) being widely recommended, it is rarely done.
Peter J Dodd, ProfPhD +3 more
doaj +1 more source
SAGE Open Medicine, 2021 Objective: Multidrug-resistant Mycobacterium tuberculosis is a public health threat in resource-limited countries where it is easily disseminated and difficult to control.
Degineh Belachew Andarge +3 more
doaj +1 more source
Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings. [PDF]
PLoS ONE, 2017 Multidrug-resistant tuberculosis has emerged as a global threat. The aim of this work was to compare the CT findings of primary multidrug-resistant tuberculosis and drug-sensitive tuberculosis in non-AIDS adults.From January 2012 to February 2016, 89 ...
Duo Li, Wei He, Budong Chen, Pingxin Lv
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Human immunodeficiency virus/tuberculosis coinfections have amplified the multidrug-resistant tuberculosis pandemic in many countries in Sub-Saharan Africa, and multidrug-resistant tuberculosis has become a major public health threat. There is
Lydia Nakiyingi +6 more
doaj +1 more source
Multidrug resistant tuberculosis [PDF]
BMJ, 2015 #### The bottom line Tuberculosis remains a major cause of morbidity and mortality globally, with an estimated nine million people developing the disease and 1.5 million deaths in 2013; equating to 4100 deaths a day.1 Nevertheless, considerable gains have been made in international tuberculosis control; incidence rates are decreasing (albeit slowly ...
Millard, James +2 more
openaire +2 more sources
Data in Brief, 2020 This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia.
Ricvan Dana Nindrea +7 more
doaj +1 more source
PLoS ONE, 2022 BackgroundThe rate of multidrug-resistant tuberculosis is increasing at an alarming rate throughout the world. It is becoming an emerging public health problem in East Africa.
Kindu Alem Molla +2 more
doaj +1 more source